A €300 million cash acquisition, plus up to €50 million earnout, will combine complementary medical laser businesses, expanding the addressable market by $1 billion and expected to be accretive to margins and earnings. Closing is targeted for Q4 2026, pending regulatory approvals.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.